Meng X, Asadi-Asadabad S, Cao S, Song R, Lin Z, Safhi M
Cell Mol Immunol. 2024; 22(1):54-67.
PMID: 39543372
PMC: 11686098.
DOI: 10.1038/s41423-024-01233-y.
Du Y, Xie J, Liu D, Zhao J, Chen P, He X
Cell Mol Immunol. 2024; 22(1):40-53.
PMID: 39516355
PMC: 11685474.
DOI: 10.1038/s41423-024-01234-x.
Zhao Y, Liu L, Hao J, Wang H, Cao Y, Lan Y
Medicine (Baltimore). 2024; 103(43):e40229.
PMID: 39470566
PMC: 11521087.
DOI: 10.1097/MD.0000000000040229.
Wu J, Zhou J, Li G, Sun X, Xiang C, Chen H
Nat Chem Biol. 2024; 21(3):371-382.
PMID: 39060389
DOI: 10.1038/s41589-024-01690-6.
Peng P, Chavel C, Liu W, Carlson L, Cao S, Utley A
Cell Rep. 2024; 43(7):114445.
PMID: 38968073
PMC: 11318075.
DOI: 10.1016/j.celrep.2024.114445.
Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target.
Zhao J, Jin D, Huang M, Ji J, Xu X, Wang F
Front Cell Dev Biol. 2024; 12:1416472.
PMID: 38933335
PMC: 11199735.
DOI: 10.3389/fcell.2024.1416472.
Ferroptosis and circular RNAs: new horizons in cancer therapy.
Bhat A, Kukreti N, Afzal M, Goyal A, Thapa R, Ali H
EXCLI J. 2024; 23:570-599.
PMID: 38887390
PMC: 11180955.
DOI: 10.17179/excli2024-7005.
Multiple roles for AU-rich RNA binding proteins in the development of haematologic malignancies and their resistance to chemotherapy.
Podszywalow-Bartnicka P, Neugebauer K
RNA Biol. 2024; 21(1):1-17.
PMID: 38798162
PMC: 11135835.
DOI: 10.1080/15476286.2024.2346688.
Conserved role of hnRNPL in alternative splicing of epigenetic modifiers enables B cell activation.
Subramani P, Fraszczak J, Helness A, Estall J, Moroy T, Di Noia J
EMBO Rep. 2024; 25(6):2662-2697.
PMID: 38744970
PMC: 11169469.
DOI: 10.1038/s44319-024-00152-3.
Inflammation as a driver of hematological malignancies.
Saluja S, Bansal I, Bhardwaj R, Beg M, Palanichamy J
Front Oncol. 2024; 14:1347402.
PMID: 38571491
PMC: 10987768.
DOI: 10.3389/fonc.2024.1347402.
Regulation of inflammatory diseases via the control of mRNA decay.
Yoshinaga M, Takeuchi O
Inflamm Regen. 2024; 44(1):14.
PMID: 38491500
PMC: 10941436.
DOI: 10.1186/s41232-024-00326-5.
Alternative splicing and related RNA binding proteins in human health and disease.
Tao Y, Zhang Q, Wang H, Yang X, Mu H
Signal Transduct Target Ther. 2024; 9(1):26.
PMID: 38302461
PMC: 10835012.
DOI: 10.1038/s41392-024-01734-2.
Translatomics to explore dynamic differences in immunocytes in the tumor microenvironment.
Guo Y, Yan S, Zhang W
Mol Ther Nucleic Acids. 2023; 34:102037.
PMID: 37808922
PMC: 10551571.
DOI: 10.1016/j.omtn.2023.102037.
NK cell expansion requires HuR and mediates control of solid tumors and long-term virus infection.
Piersma S, Bangru S, Yoon J, Liu T, Yang L, Hsieh C
J Exp Med. 2023; 220(11).
PMID: 37698554
PMC: 10497399.
DOI: 10.1084/jem.20231154.
The role of TIA1 and TIAL1 in germinal center B cell function and survival.
Wang Y, Liu J, Zhou F
Cell Mol Immunol. 2023; 20(9):1090-1092.
PMID: 37626212
PMC: 10468532.
DOI: 10.1038/s41423-023-01067-0.
The RNA binding proteins TIA1 and TIAL1 promote Mcl1 mRNA translation to protect germinal center responses from apoptosis.
Osma-Garcia I, Mouysset M, Capitan-Sobrino D, Aubert Y, Turner M, Diaz-Munoz M
Cell Mol Immunol. 2023; 20(9):1063-1076.
PMID: 37474714
PMC: 10469172.
DOI: 10.1038/s41423-023-01063-4.
Reclassification of Splicing Gene Variants in Hereditary Cancer: Cases Report and Literature Review.
Bouzarelou D, Agiannitopoulos K, Tsaousis G, Papadopoulou E, Nasioulas G
In Vivo. 2023; 37(4):1432-1444.
PMID: 37369490
PMC: 10347938.
DOI: 10.21873/invivo.13227.
Post-transcriptional checkpoints in autoimmunity.
Bechara R, Vagner S, Mariette X
Nat Rev Rheumatol. 2023; 19(8):486-502.
PMID: 37311941
DOI: 10.1038/s41584-023-00980-y.
REPAC: analysis of alternative polyadenylation from RNA-sequencing data.
Imada E, Wilks C, Langmead B, Marchionni L
Genome Biol. 2023; 24(1):22.
PMID: 36759904
PMC: 9912678.
DOI: 10.1186/s13059-023-02865-5.
Towards resolution of the intron retention paradox in breast cancer.
Shah J, Milevskiy M, Petrova V, Au A, Wong J, Visvader J
Breast Cancer Res. 2022; 24(1):100.
PMID: 36581993
PMC: 9798573.
DOI: 10.1186/s13058-022-01593-1.